The Role of Angiotensin Type I Receptor in the Regulation of Human Peripheral Vascular Function

NCT00001628 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

36

Enrollment

NIH

Sponsor class

Conditions

Atherosclerosis
Heart Failure, Congestive
Hypertension
Myocardial Infarction

Interventions

DRUG: Angiotensin II type 1 receptor antagonists

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)